Product Introduction
FOXO4-DRI is a synthetic peptide derived from the FOXO4 protein sequence with a D-retro-inverso (DRI) modification, widely studied in peptide and molecular biology research. It is commonly used in laboratory studies involving protein-protein interactions, cellular signaling pathways, and peptide-based experimental models.
Our FOXO4-DRI Powder is produced using solid-phase peptide synthesis (SPPS) and purified through high-performance liquid chromatography (HPLC), ensuring high purity, structural stability, and consistent batch quality.
It is suitable for research institutions, laboratories, and advanced peptide research applications.
Product Parameters
|
Parameter |
Specification |
|
Product Name |
FOXO4-DRI |
|
CAS No. |
N/A |
|
Appearance |
White lyophilized powder |
|
Purity |
≥98% (HPLC) |
|
Type |
Synthetic modified peptide |
|
Modification |
D-retro-inverso (DRI) |
|
Molecular Formula |
Available upon request |
|
Molecular Weight |
Available upon request |
|
Sequence |
Available upon request |
|
Dosage Form |
10mg per vial |
|
Solubility |
Soluble in water or buffer |
|
Storage |
-20°C (long term) |
|
Shelf Life |
2 years |
|
Grade |
Research Grade |
Product Features & Applications
Key Features
- Modified peptide with enhanced stability (DRI)
- High purity with consistent batch quality
- Reliable peptide structure
- Low endotoxin level
- Verified by HPLC and mass spectrometry
Applications
- Protein-protein interaction studies
- Cellular and molecular biology research
- Peptide-based experimental models
- Advanced signaling pathway research
Product Details
Manufacturing Process
- Solid-phase peptide synthesis (SPPS)
- D-retro-inverso modification
- High-purity HPLC purification
- Mass spectrometry (MS) confirmation
Quality Control
Each batch undergoes:
- HPLC purity analysis
- Molecular verification (MS)
- Stability and consistency testing
Product Qualification
- GMP-compliant production environment
- ISO-certified quality management system
- Professional peptide R&D team
- Full traceability from raw materials to finished product
Available documents:
- Certificate of Analysis (COA)
- HPLC chromatogram
- MS spectrum
Shipping & Service
- Packaging: Sterile vial, lyophilized powder format, securely sealed
- Shipping Methods: Air freight, sea freight, and express delivery available
- Express Couriers: UPS, FedEx, Royal Mail
- Shipping Conditions: Cold chain or insulated packaging recommended
- Lead Time: 3–7 working days after order confirmation
- Supply Capability: Bulk and wholesale orders supported
- Customization: Sequence, purity level, and packaging options available
- Technical Support: Professional peptide consultation and after-sales service
FAQ
Q1: What is FOXO4-DRI?
A: It is a modified peptide derived from FOXO4 with D-retro-inverso structure for enhanced stability in research use.
Q2: What packaging size is available?
A: 10mg per vial. Custom sizes are available.
Q3: How should FOXO4-DRI be stored?
A: Store at -20°C and avoid repeated freeze-thaw cycles.
Q4: Do you provide COA and analytical data?
A: Yes, COA, HPLC, and MS reports are provided.
Q5: Is customization available?
A: Yes, sequence and purity can be customized.
Disclaimer
For research use only. Not for human or animal use.
Hot Tags: foxo4-dri powder, China foxo4-dri powder suppliers, manufacturers, factory, BPC 157 Peptide Powder, CJC 1295 Without DAC And Ipamorelin Blend Powder, Pure Tesamorelin Powder, Semax Peptide Powder, Thymogen Powder, Vesugen Powder



